Francesca Lunghi Selected Research

Francesca Lunghi Research Topics

9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 01/2018
6	Neoplasms (Cancer) 01/2023 - 10/2007
4	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 09/2016
3	Polycythemia Vera 06/2023 - 01/2013
2	Essential Thrombocythemia 01/2024 - 01/2021
2	Leukemia 01/2021 - 12/2019
2	COVID-19 01/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 06/2013 - 02/2009
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2024
1	Blast Crisis (Blast Phase) 11/2023
1	Disease Progression 11/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Stroke (Strokes) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Infections 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Philadelphia Chromosome 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Diarrhea 09/2020
1	Fatigue 09/2020
1	Edema (Dropsy) 09/2020
1	Muscle Cramp (Cramp) 09/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Anemia 01/2020
1	Hematologic Diseases (Blood Diseases) 12/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Ischemic Stroke 01/2018
1	Transient Ischemic Attack 01/2018
1	Iron Overload 09/2016
1	Splenomegaly 09/2016
1	Hodgkin Disease (Hodgkin's Disease) 04/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2008
1	Lymphoma (Lymphomas) 04/2008

9	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2019
4	ruxolitinibIBA 01/2022 - 01/2019
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2024 - 01/2013
3	nilotinib FDA Link 01/2023 - 01/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2013 - 10/2007
2	fludarabineIBA 07/2023 - 09/2016
2	treosulfanIBA 07/2023 - 09/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 09/2020
1	Janus Kinase InhibitorsIBA 07/2023
1	Sirolimus (Rapamycin)FDA Link 07/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	bcr-abl Fusion ProteinsIBA 10/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Pipobroman (Vercyte)FDA Link 01/2019
1	Drug CombinationsIBA 01/2019
1	Thymidine KinaseIBA 06/2013
1	VaccinesIBA 02/2009
1	2- (2- (1- phenyl- 4- piperazynyl)ethyl)- 1,2,3,4- tetrahydro- beta- carboline- 1- spiro- 4'- N'- benzylpiperidineIBA 04/2008
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2007
1	Proteins (Proteins, Gene)FDA Link 10/2007
1	Cancer VaccinesIBA 10/2007
1	AntigensIBA 10/2007

5	Therapeutics 06/2023 - 01/2018
3	Stem Cell Transplantation 07/2023 - 04/2008
1	Aftercare (After-Treatment) 11/2023
1	Homologous Transplantation 09/2016
1	Drug Therapy (Chemotherapy) 04/2008